Longitudinal assessment of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): lack of practice effect in ALS patients?

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

• Publication date

  2017-02-06

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1080/21678421.2017.1283418PMID 28165766
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Edinburgh Cognitive and Behavioural ALS Screen in a Chinese Amyotrophic Lateral Sclerosis Population

  2016cited by this paper
• Motor function and behaviour across the ALS‐FTD spectrum

  2016cited by this paper
• The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS)

  2016cited by this paper
• Validation of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): A cognitive tool for motor disorders

  2015cited by this paper
• No Change in Executive Performance in ALS Patients: A Longitudinal Neuropsychological Study

  2015cited by this paper
• The UCSF screening exam effectively screens cognitive and behavioral impairment in patients with ALS

  2015cited by this paper
• The Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen: A cross-sectional comparison of established screening tools in a German-Swiss population

  2015influential reference
• Semantic deficits in amyotrophic lateral sclerosis

  2015cited by this paper
• A novel tool to detect behavioural symptoms in ALS

  2014cited by this paper
• Screening for cognition and behaviour changes in ALS

  2014cited by this paper
• Randomized controlled trials in frontotemporal dementia: cognitive and behavioral outcomes

  2014cited by this paper
• Screening for frontal lobe and general cognitive impairment in patients with amyotrophic lateral sclerosis.

  2014cited by this paper
• Practice Effects and Longitudinal Cognitive Change in Normal Aging vs. Incident Mild Cognitive Impairment and Dementia in The Mayo Clinic Study of Aging

  2013cited by this paper
• Is the Frontal Assessment Battery reliable in ALS patients?

  2013cited by this paper
• Response to ‘Exploring limits of neuropsychological screening in ALS: The FAB problem’

  2013cited by this paper
• Exploring limits of neuropsychological screening in ALS: The FAB problem

  2013cited by this paper
• Behavior Matters—Cognitive Predictors of Survival in Amyotrophic Lateral Sclerosis

  2013cited by this paper
• Practice effects in a longitudinal, multi-center Alzheimer’s disease prevention clinical trial

  2012cited by this paper
• Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study

  2012cited by this paper
• Caregiver burden in amyotrophic lateral sclerosis is more dependent on patients’ behavioral changes than physical disability: a comparative study

  2012cited by this paper
• Cognitive screening in patients with amyotrophic lateral sclerosis in early stages

  2012cited by this paper
• Practice effects predict cognitive outcome in amnestic mild cognitive impairment.

  2011cited by this paper
• Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia

  2011cited by this paper
• Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.

  2011influential reference
• Terminal decline and practice effects in older adults without dementia

  2011cited by this paper
• Declines in Problem Solving and Anosognosia in Amyotrophic Lateral Sclerosis: Application of Guilford's Structure of Intellect Theory

  2011cited by this paper
• Neurobehavioral symptoms in ALS are negatively related to caregivers’ burden and quality of life

  2010cited by this paper
• Detecting frontotemporal dysfunction in ALS: Utility of the ALS Cognitive Behavioral Screen (ALS-CBS™)

  2010cited by this paper
• A prospective cohort study of neuropsychological test performance in ALS

  2010cited by this paper
• Motor neuron disease and frontotemporal dementia: One, two, or three diseases?

  2010cited by this paper
• Frontotemporal dementia and motor neurone disease: overlapping clinic-pathological disorders.

  2009cited by this paper
• Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis

  2009cited by this paper
• A screening assessment of cognitive impairment in patients with ALS

  2007cited by this paper
• Amyotrophic Lateral Sclerosis: ethical issues from diagnosis to end of life.

  2007cited by this paper
• Predictors of psychological distress in carers of people with amyotrophic lateral sclerosis: a longitudinal study

  2006cited by this paper
• Cognitive functioning in sporadic amyotrophic lateral sclerosis: a six month longitudinal study

  2006cited by this paper
• Dissociating apathy and depression in Parkinson disease

  2006cited by this paper
• Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS

  2006cited by this paper
• A rapid screening battery to identify frontal dysfunction in patients with ALS

  2006cited by this paper
• Cognitive change in ALS

  2005cited by this paper
• Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study.

  2005cited by this paper
• Cognitive function in bulbar– and spinal–onset amyotrophic lateral sclerosis

  2005cited by this paper
• The effects of executive and behavioral dysfunction on the course of ALS

  2005cited by this paper
• A longitudinal study of the evolution of cognitive function and affective state in patients with amyotrophic lateral sclerosis

  2004cited by this paper
• Complex Cognitive Disruption in Motor Neuron Disease

  2002cited by this paper
• The FAB: A frontal assessment battery at bedside

  2001cited by this paper
• El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis

  2000cited by this paper
• The FAB: A frontal assessment battery at bedside

  2000cited by this paper
• Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS)

  2000cited by this paper
• A prospective study of cognitive impairment in ALS

  1999cited by this paper
• Cognitive testing of elderly Chinese people in Singapore: influence of education and age on normative scores.

  1997cited by this paper
• A 5-year longitudinal study of the Mini-Mental State Examination in normal aging.

  1997cited by this paper
• Performance on a dementia screening test in relation to demographic variables. Study of 5297 community residents in Taiwan.

  1994cited by this paper
• Human Experimentation: Code of Ethics of W.M.A

  1964cited by this paper
• HUMAN EXPERIMENTATION. CODE OF ETHICS OF THE WORLD MEDICAL ASSOCIATION. DECLARATION OF HELSINKI.

  1964cited by this paper

• EARLY COGNITIVE DECLINE IN AMYOTROPHIC LATERAL SCLEROSIS AND ITS RELATION TO DRIVING: AN OBSERVATIONAL STUDY

  2025influential citation
• The Effect of Repetitive Transcranial Magnetic Stimulation of the Dorsolateral Prefrontal Cortex on the Amyotrophic Lateral Sclerosis Patients With Cognitive Impairment: A Double‐Blinded, Randomized, and Sham Control Trial

  2025cites this paper
• Educational adjustments for the Chinese version of the Edinburgh Cognitive and Behavioral Screen (ECAS): establishing normative data

  2025cites this paper
• Psychological resilience is protective against cognitive deterioration in motor neuron diseases

  2024cites this paper
• The Basis of Cognitive and Behavioral Dysfunction in Amyotrophic Lateral Sclerosis

  2024cites this paper
• Adaptation and Validation of Version B of the Edinburgh Cognitive and Behavioural ALS Screen for the Portuguese Population.

  2024cites this paper
• Repeated cognitive assessments show stable function over time in patients with ALS

  2024cites this paper
• Norwegian version of the Edinburgh cognitive and behavioural ALS screen: Construct validity, internal consistency, inter-rater, and test-retest reliability

  2023cites this paper
• Cognitive performance of adult patients with SMA before and after treatment initiation with nusinersen

  2023cites this paper
• Cognition in the course of ALS—a meta-analysis

  2022cites this paper
• Reliable change indices for the Italian Edinburgh Cognitive and Behavioral ALS Screen (ECAS)

  2022cites this paper
• Apathy in amyotrophic lateral sclerosis: systematic review and meta-analysis of frequency, correlates, and outcomes

  2022cites this paper
• Mild behavioral impairment as a potential marker of predementia risk states in motor neuron diseases

  2022cites this paper
• Progression of cognitive and behavioral disturbances in motor neuron diseases assessed using standard and computer-based batteries

  2021cites this paper
• Cognitive and behavioural impairment in amyotrophic lateral sclerosis: a landmark of the disease? A mini review of longitudinal studies.

  2021cites this paper
• Prognosis of amyotrophic lateral sclerosis with cognitive and behavioural changes based on a sixty-month longitudinal follow-up

  2021cites this paper
• Phase 1b dose-escalation, safety, and pharmacokinetic study of IC14, a monoclonal antibody against CD14, for the treatment of amyotrophic lateral sclerosis

  2021cites this paper
• PROM_A_256828 181..194

  2020cites this paper
• The impact of cognitive and behavioral impairment in amyotrophic lateral sclerosis

  2020cites this paper
• An overview of screening instruments for cognition and behavior in patients with ALS: selecting the appropriate tool for clinical practice

  2020cites this paper
• Progression of cognitive and behavioural impairment in early amyotrophic lateral sclerosis

  2020cites this paper
• Human salivary Raman fingerprint as biomarker for the diagnosis of Amyotrophic Lateral Sclerosis

  2020cites this paper
• Psychometric Properties of Cognitive Assessment in Amyotrophic Lateral Sclerosis: A Systematic Review

  2020cites this paper
• Longitudinal clinical and neuroanatomical correlates of memory impairment in motor neuron disease

  2020cites this paper
• Measuring disease progression in primary lateral sclerosis

  2020cites this paper
• Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

  2019cites this paper
• Tracking a Fast-Moving Disease: Longitudinal Markers, Monitoring, and Clinical Trial Endpoints in ALS

  2019cites this paper
• Edinburgh Cognitive and Behavioral Amyotrophic Lateral Sclerosis Screen (ECAS) in Norway: Protocol for validation and a prospective cohort study

  2019cites this paper
• Cognitive, Emotional and Psychological Manifestations in Amyotrophic Lateral Sclerosis at Baseline and Overtime: A Review

  2019cites this paper
• Equivalency and practice effects of alternative versions of the Edinburgh Cognitive and Behavioral ALS Screen (ECAS)

  2019cites this paper
• Relationship between neuropsychiatric disorders and cognitive and behavioural change in MND

  2019cites this paper
• CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis

  2018cites this paper
• Cognitive-behavioural longitudinal assessment in ALS

  2018cites this paper
• Neuropsychological functioning across the ALS disease course and its assessment

  2018cites this paper
• ECAS A-B-C: alternate forms of the Edinburgh Cognitive and Behavioural ALS Screen

  2018cites this paper
• Measuring reliable change in cognition using the Edinburgh Cognitive and Behavioural ALS Screen (ECAS)

  2018cites this paper
• Cognitive-behavioral longitudinal assessment in ALS: the Italian Edinburgh Cognitive and Behavioral ALS screen (ECAS)

  2018influential citation
• Measuring reliable change in cognition using the Edinburgh Cognitive and Behavioural ALS Screen (ECAS)

  2017cites this paper
• Considerations for Clinical Neuropsychological Evaluation in Amyotrophic Lateral Sclerosis.

  2017cites this paper